Atrium Therapeutics, Inc. · NASDAQ:RNA
BlackRock, Inc. reported a 5.20% stake in Atrium Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc. reported a 5.20% stake in Atrium Therapeutics, Inc., 892,387 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 892,387
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.20% | 892,387 |
Source
Related
- Atrium Therapeutics, Inc.
- BlackRock, Inc.
- Atrium Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026